Stay updated on Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    1%
    Check dated 2025-06-20T21:26:01.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T16:34:20.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T10:29:06.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page now indicates that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation.
    Difference
    3%
    Check dated 2025-05-30T06:11:30.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-23T02:27:15.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:32:17.000Z thumbnail image

Stay in the know with updates to Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Short Course Daratumumab in Patients With Multiple Myeloma Clinical Trial page.